These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

615 related items for PubMed ID: 11889422

  • 1. Survival of fetal skin grafts is prolonged on the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient mouse/skin allograft model.
    Erdag G, Morgan JR.
    Transplantation; 2002 Feb 27; 73(4):519-28. PubMed ID: 11889422
    [Abstract] [Full Text] [Related]

  • 2. Allogeneic versus xenogeneic immune reaction to bioengineered skin grafts.
    Erdag G, Morgan JR.
    Cell Transplant; 2004 Feb 27; 13(6):701-12. PubMed ID: 15648740
    [Abstract] [Full Text] [Related]

  • 3. The allogeneic response to cultured human skin equivalent in the hu-PBL-SCID mouse model of skin rejection.
    Briscoe DM, Dharnidharka VR, Isaacs C, Downing G, Prosky S, Shaw P, Parenteau NL, Hardin-Young J.
    Transplantation; 1999 Jun 27; 67(12):1590-9. PubMed ID: 10401767
    [Abstract] [Full Text] [Related]

  • 4. Dermal microvascular injury in the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient (HuPBL-SCID) mouse/skin allograft model is T cell mediated and inhibited by a combination of cyclosporine and rapamycin.
    Murray AG, Schechner JS, Epperson DE, Sultan P, McNiff JM, Hughes CC, Lorber MI, Askenase PW, Pober JS.
    Am J Pathol; 1998 Aug 27; 153(2):627-38. PubMed ID: 9708821
    [Abstract] [Full Text] [Related]

  • 5. Delayed rejection of fetal pig pancreas in CD4 cell deficient mice was correlated with residual helper activity.
    Zhan Y, Corbett AJ, Brady JL, Sutherland RM, Lew AM.
    Xenotransplantation; 2000 Nov 27; 7(4):267-74. PubMed ID: 11081761
    [Abstract] [Full Text] [Related]

  • 6. Alloimmune injury and rejection of human skin grafts on human peripheral blood lymphocyte-reconstituted non-obese diabetic severe combined immunodeficient beta2-microglobulin-null mice.
    Turgeon NA, Banuelos SJ, Shultz LD, Lyons BL, Iwakoshi N, Greiner DL, Mordes JP, Rossini AA, Appel MC.
    Exp Biol Med (Maywood); 2003 Oct 27; 228(9):1096-104. PubMed ID: 14530522
    [Abstract] [Full Text] [Related]

  • 7. Chronic human skin graft rejection in severe combined immunodeficient mice engrafted with human PBL from an HLA-presensitized donor.
    Kawamura T, Niguma T, Fechner JH, Wolber R, Beeskau MA, Hullett DA, Sollinger HW, Burlingham WJ.
    Transplantation; 1992 Mar 27; 53(3):659-65. PubMed ID: 1549862
    [Abstract] [Full Text] [Related]

  • 8. The degree of phylogenetic disparity of islet grafts dictates the reliance on indirect CD4 T-cell antigen recognition for rejection.
    Rayat GR, Johnson ZA, Beilke JN, Korbutt GS, Rajotte RV, Gill RG.
    Diabetes; 2003 Jun 27; 52(6):1433-40. PubMed ID: 12765954
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prolonged survival of fetal pig islet xenografts in mice lacking the capacity for an indirect response.
    Koulmanda M, Laufer TM, Auchincloss H, Smith RN.
    Xenotransplantation; 2004 Nov 27; 11(6):525-30. PubMed ID: 15479462
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The critical role of mouse CD4+ cells in the rejection of highly disparate xenogeneic pig thymus grafts.
    Zhao Y, Swenson K, Wekerle T, Rodriguez-Barbosa JI, Arn JS, Sykes M.
    Xenotransplantation; 2000 May 27; 7(2):129-37. PubMed ID: 10961297
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Human leukocyte antigen-DR matching improved skin graft survival from transgenic pigs to accommodate SCID mice reconstituted with human peripheral blood mononuclear cells.
    Tu CF, Tai HC, Chen CM, Huang TT, Lee JM, Yang TS, Chen CH, Tseng YL, Chou NK, Lee PH.
    Transplant Proc; 2008 Mar 27; 40(2):578-80. PubMed ID: 18374133
    [Abstract] [Full Text] [Related]

  • 15. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.
    Qian S, Fu F, Li Y, Lu L, Rao AS, Starzl TE, Thomson AW, Fung JJ.
    Immunology; 1996 May 27; 88(1):124-9. PubMed ID: 8707337
    [Abstract] [Full Text] [Related]

  • 16. Chronic antagonism of Mig inhibits cellular infiltration and promotes survival of class II MHC disparate skin allografts.
    Kobayashi H, Novick AC, Toma H, Fairchild RL.
    Transplantation; 2002 Aug 15; 74(3):387-95. PubMed ID: 12177619
    [Abstract] [Full Text] [Related]

  • 17. Islet allograft, islet xenograft, and skin allograft survival in CD8+ T lymphocyte-deficient mice.
    Desai NM, Bassiri H, Kim J, Koller BH, Smithies O, Barker CF, Naji A, Markmann JF.
    Transplantation; 1993 Apr 15; 55(4):718-22. PubMed ID: 8475541
    [Abstract] [Full Text] [Related]

  • 18. Prolonged skin allograft survival in Scid mice reconstituted with isogeneic bone marrow stem cell antigen-1-positive cells and thymus tissue.
    Gao Z, Tibbles L, Yilmaz S, Gao Y, MacDonald A.
    Transplant Proc; 2005 Jun 15; 37(5):2300-2. PubMed ID: 15964404
    [Abstract] [Full Text] [Related]

  • 19. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
    Tsuchida M, Brown SA, Tutt LM, Tan J, Seehafer DL, Harris JP, Xun CQ, Thompson JS.
    Clin Transplant; 1997 Oct 15; 11(5 Pt 2):522-8. PubMed ID: 9361954
    [Abstract] [Full Text] [Related]

  • 20. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
    Han WR, Zhan Y, Murray-Segal LJ, Brady JL, Lew AM, Mottram PL.
    Transplantation; 2000 Jul 15; 70(1):168-74. PubMed ID: 10919596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.